Fifth Third Bancorp
RARE icon

Fifth Third Bancorp’s Ultragenyx Pharmaceutical RARE Stock Holding History

Fifth Third Bancorp’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.45M Buy
193,236
+82,964
+75% +$2.06M 0.01% 658
2026
Q1 		$2.31M Buy
+110,272
New +$2.48M ﹤0.01% 1144
2019
Q1 		– Sell
-1
Closed – – 2279
2018
Q4 		$0 Sell
1
-126
-99% -$6.89K ﹤0.01% 2325
2018
Q3 		$10K Sell
127
-111
-47% -$9.03K ﹤0.01% 1833
2018
Q2 		$18K Hold
238
– – ﹤0.01% 1697
2018
Q1 		$12K Hold
238
– – ﹤0.01% 1845
2017
Q4 		$11K Sell
238
-813
-77% -$39.9K ﹤0.01% 1802
2017
Q3 		$56K Sell
1,051
-196
-16% -$11.6K ﹤0.01% 1257
2017
Q2 		$77K Buy
1,247
+1,178
+1,707% +$71K ﹤0.01% 1148
2017
Q1 		$5K Sell
69
-735
-91% -$56K ﹤0.01% 1852
2016
Q4 		$57K Sell
804
-618
-43% -$43.8K ﹤0.01% 1290
2016
Q3 		$101K Buy
1,422
+173
+14% +$11K ﹤0.01% 1101
2016
Q2 		$61K Sell
1,249
-111
-8% -$7.18K ﹤0.01% 1225
2016
Q1 		$86K Buy
+1,360
New +$89K ﹤0.01% 1140
2015
Q4 		– Sell
-7
Closed -$1K – 2851
2015
Q3 		$1K Buy
+7
New +$801 ﹤0.01% 2775

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Fifth Third Bancorp's RARE Position: Q2 2026 in Review

Fifth Third Bancorp increased its Ultragenyx Pharmaceutical (RARE) stake by 75% in Q2 2026, buying an estimated $2.06M and bringing the position to 193,236 shares worth $6.45M. The position accounts for 0.01% of the portfolio, ranked #658.

Fifth Third Bancorp first reported a position in RARE in Q3 2015 and has held it in 15 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Fifth Third Bancorp held 193,236 shares of Ultragenyx Pharmaceutical worth $6.45M as of Q2 2026.
  • Fifth Third Bancorp bought 82,964 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $2.06M.
  • Ultragenyx Pharmaceutical made up 0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #658 holding.
  • Fifth Third Bancorp first reported a position in Ultragenyx Pharmaceutical in Q3 2015 and has held it in 15 quarters since.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.